In the pre-immune checkpoint inhibitor (ICI) era, patients with advanced cSCC had poor long-term outcomes to palliative chemotherapy and epidermal growth factor receptor (EGFR) inhibitors [18,19,20,21,22,23]. Here, EGFR is linked to skin squamous cell carcinoma.